UK markets closed

Aurobindo Pharma Limited (AUROPHARMA.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
854.90-8.25 (-0.96%)
At close: 3:57PM IST
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2020
31/03/2019
31/03/2018
31/03/2017
Total revenue
246,296,800
227,379,600
192,259,300
161,992,100
146,639,400
Cost of revenue
105,052,700
102,417,400
92,596,600
71,529,500
67,790,700
Gross profit
141,244,100
124,962,200
99,662,700
90,462,600
78,848,700
Operating expenses
Research development
-
1,217,900
756,300
292,200
165,800
Selling general and administrative
-
14,930,200
9,298,200
9,131,000
9,570,300
Total operating expenses
97,010,600
85,546,400
66,578,200
57,788,400
48,427,500
Operating income or loss
44,233,500
39,415,800
33,084,500
32,674,200
30,421,200
Interest expense
699,600
1,416,300
1,507,800
628,900
545,100
Income before tax
73,602,600
37,430,400
30,913,500
32,411,800
30,608,400
Income tax expense
19,786,100
9,135,200
7,268,500
8,182,700
7,596,500
Income from continuing operations
53,816,500
28,295,200
23,645,000
24,229,100
23,011,900
Net income
53,831,000
28,309,700
23,647,300
24,231,700
23,016,600
Net income available to common shareholders
53,831,000
28,309,700
23,647,300
24,231,700
23,016,600
Basic EPS
-
48.32
40.36
41.36
39.33
Diluted EPS
-
48.32
40.36
41.36
39.33
Basic average shares
-
585,931
585,908
585,883
585,214
Diluted average shares
-
585,931
585,936
585,888
585,223
EBITDA
-
48,513,800
39,100,800
38,620,400
35,429,800